Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYMBanks - Regional
+$0.15 today
- Market cap
- $12.16B
- Beta
- 0.76
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$2.54
Volume 5.80M
Average 4.76M
CHYM Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Chime Financial, Inc. Class A Common StockNASDAQ: CHYM
Revenue · Q2 FY2026 · quarter ended Jun 2026
Revenue grows, but more slowly than its trailing trend
Q2 FY2026 revenue of $576.97M rose 9.2% year over year, behind the +21.6% change in trailing-twelve-month revenue. Sequentially, it fell 10.9% from the prior quarter. Over 3 fiscal years it compounded at +29.4% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 16 analysts of $2.8B (+28.1%) for the fiscal year ending Dec 2026, a slowdown from the +30.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $576.97M-10.9% QoQ
- Last fiscal yearDec 2025
- $2.19B+30.7% YoY
- LTMJun 2026
- $2.36B+21.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +9.2% | +29.7% | +20.4 pp |
| 1 year | +30.7% | +28.1% | -2.6 pp |
| 3-year CAGR | +29.4% | +23.7% | -5.7 pp |
| 5-year CAGR | +17.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 2.19B USD
- Year-over-year change
- +30.7%
- 3-year CAGR
- +29.4%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.19B | +30.7% |
| FY2024 | 2024-12-31 | 1.67B | +30.9% |
| FY2023 | 2023-12-31 | 1.28B | +26.7% |
| FY2022 | 2022-12-31 | 1.01B | — |
Revenue vs competitors
How CHYM compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of +21.6% is the 4th highest of 7, against a peer median of +22.4%.
- Over three fiscal years its annual growth of +29.4% compares with a peer median of +20.4%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | ¥395.79B JPY | +28.9% | +27.0% | |
| LTM Jun 2026 | $35.08B USD | +16.0% | +13.8% | |
| LTM Jun 2026 | $34.13B USD | +5.7% | +6.4% | |
| LTM Sep 2026 | $20.81B USD | +49.0% | +52.0% | |
| LTM Jun 2026 | $10.19B USD | +14.8% | -5.0% | |
| LTM Jun 2026 | $2.36B USD | +21.6% | +29.4% | |
| LTM Jun 2026 | $643.65M USD | +48.6% | +39.3% | |
| Peer median (excluding CHYM) | — | +22.4% | +20.4% | |
Competitors are the stored peer set for CHYM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 1.01B | 1.28B | 1.67B | 2.19B |
| Cost of Revenue | 214.69M | 219.74M | 207.51M | 309.03M |
| Gross Profit | 794.15M | 1.06B | 1.47B | 1.88B |
| Gross Margin | 78.7% | 82.8% | 87.6% | 85.9% |
| Research & Development | 242.43M | 259M | 309.58M | 934.93M |
| Selling, General & Admin | 603.94M | 598.75M | 696.99M | 1.15B |
| Operating Expenses | 1.27B | 1.29B | 1.53B | 2.92B |
| Depreciation & Amortization | 7.3M | 12.94M | 25.37M | 30M |
| EBITDA | (471.4M) | (222.85M) | (36.83M) | (979.11M) |
| EBITDA Margin | -46.7% | -17.4% | -2.2% | -44.8% |
| Operating Income | (478.7M) | (235.79M) | (62.2M) | (1.04B) |
| Operating Margin | -47.5% | -18.4% | -3.7% | -47.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 8.11M | 32.82M | 39.47M | 30.87M |
| Income Before Tax | (470.59M) | (202.97M) | (22.73M) | (1.01B) |
| Pre-Tax Margin | -46.6% | -15.9% | -1.4% | -46.1% |
| Income Tax Expense | (337K) | 234K | 2.61M | 831K |
| Net Income | (470.25M) | (203.2M) | (25.34M) | (1.01B) |
| Net Margin | -46.6% | -15.9% | -1.5% | -46.2% |
| EPS (Basic) | (1.29) | (0.56) | (0.07) | (2.67) |
| EPS (Diluted) | (1.29) | (0.56) | (0.07) | (2.60) |
| Weighted Avg Shares | 364.42M | 364.42M | 364.42M | 378.75M |
| Weighted Avg Shares (Diluted) | 364.42M | 364.42M | 364.42M | 388.17M |
Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYM
Intrinsic Alpha fair value
Locked
Current Price
$32.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.